42 participants
A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-11-02
- Start Date:
- 2006-07-31
- Completion:
- 2012-03-31
Conditions
- Colorectal Cancer
Interventions
- DRUG
No Results Yet